Ketoconazol Kern Pharma (Ketoconazole)

Ketoconazole blocks the fungal enzyme lanosterol 14α‑demethylase, which is essential for producing ergosterol, a key component of fungal cell membranes. Inhibiting ergosterol synthesis disrupts membrane integrity, leading to increased permeability and cell death. This mechanism limits fungal growth on the skin and facilitates resolution of the infection.

The specific dose and duration of Ketoconazol Kern Pharma are determined by the prescribing healthcare professional based on the type and severity of the infection, the patient’s age, and other clinical factors. Patients should follow the prescriber’s instructions and the product label for proper application frequency and treatment length.

Safety data for ketoconazole use in pregnancy and lactation are limited. It is generally advised to avoid topical ketoconazole during pregnancy unless the potential benefit justifies the risk, and to consider the unknown risk to a nursing infant. Healthcare providers should evaluate individual circumstances before prescribing.

To request Ketoconazol Kern Pharma, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, and will ask for trade or institutional credentials. The sales team will then provide pricing, availability, shipping details (including any cold‑chain requirements) and assist with import documentation.

Ketoconazol is an imidazole antifungal that offers broad‑spectrum activity against dermatophytes and yeasts, making it suitable for conditions like tinea infections and seborrheic dermatitis. Compared with allylamine agents such as terbinafine, ketoconazole may have a slower onset but is effective for a wider range of fungal species. Choice of therapy depends on infection type, patient tolerance and clinician preference.

Ketoconazol Kern Pharma should be stored at room temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed when not in use to maintain stability and potency.

The product is applied topically to the affected skin area, typically once or twice daily as directed by a healthcare professional. The skin should be clean and dry before application. A thin layer is spread over the lesion and gently rubbed in until fully absorbed. Hands should be washed after use to avoid accidental contact with eyes or mucous membranes.

Serious risks, though rare, include severe allergic reactions such as angioedema or anaphylaxis, extensive contact dermatitis, and severe cutaneous adverse reactions like Stevens‑Johnson syndrome or toxic epidermal necrolysis. Systemic absorption can rarely cause liver enzyme elevations. Patients should discontinue use and seek medical attention if they experience signs of a serious reaction.

Ketoconazol Kern Pharma should be avoided in individuals with known hypersensitivity to ketoconazole or any component of the formulation. It is also contraindicated on severely damaged or broken skin, and should be used with caution in patients with liver disease or those taking other hepatotoxic medications. Pregnant or breastfeeding women should consult their clinician before use.